Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate | Zendy

A. Hutchison | Zendy; Andrew Whelton | Zendy; Ravi Thadhani | Zendy; Heinrich Achenbach | Zendy; Andrea Vergani | Zendy; Jingyang Wu | Zendy; Gillian C. Hall | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate

Author(s) -

A. Hutchison,

Andrew Whelton,

Ravi Thadhani,

Heinrich Achenbach,

Andrea Vergani,

Jingyang Wu,

Gillian C. Hall

Publication year - 2018

Publication title -

the nephron journals/nephron journals

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.951

H-Index - 72

eISSN - 2235-3186

pISSN - 1660-8151

DOI - 10.1159/000492603

Subject(s) - medicine , lanthanum carbonate , end stage renal disease , kidney disease , nephrology , disease , stage (stratigraphy) , intensive care medicine , term (time) , lanthanum , surgery , hyperphosphatemia , physics , paleontology , inorganic chemistry , chemistry , quantum mechanics , biology

This post-marketing observational study assessed the long-term safety of lanthanum carbonate (LaC) in US patients with end-stage renal disease (NCT00567723).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research